Sincere pharmaceutical "three centers" officially settled in Shanghai

[China Pharmaceutical network enterprise news] on the morning of June 19, Zhejiang sincerity Pharmaceutical Co., Ltd held the "marketing center, technology development center and securities affairs center" entry ceremony in Shanghai Hongqiao Fuli center, officially stepping out of the key step from "offshore" to Shanghai With the completion of the on-site ribbon cutting and finishing ceremony, the "three centers" of sincere pharmaceutical industry were officially settled in Shanghai Yan Yiyi, chairman of Zhejiang sincerity Pharmaceutical Co., Ltd (hereinafter referred to as "sincerity pharmaceutical"), said that after the "three centers" settled in Shanghai, sincerity pharmaceutical will attract more pharmaceutical commercial companies to join in through this platform and attract elites and teams from home and abroad to join in First of all, it will make a breakthrough in the reform of marketing mode and truly realize the leap from "offshore" to Shanghai 。 On March 15 last year, sincerity pharmaceutical was listed on the main board of Shanghai Stock Exchange From relying on Shanghai's talent advantage, information advantage and R & D advantage in the past to setting up its own "window" in this international metropolis today, sincerity pharmaceutical realized a magnificent turn in the development of enterprises In the past year, the sincerity pharmaceutical industry has been making continuous progress, focusing on three business tasks: first, focusing on marketing, changing the general agent sales mode to the provincial agent and self operation mode, focusing on the sales of characteristic products, and promoting the market share of three major varieties and 15 key products, and achieved good results In the first quarter of this year, the company achieved an operating revenue of 123 million yuan, a year-on-year increase of 49.47%, and a net profit of 17.82 million yuan, a year-on-year increase of 26%; secondly, the company focused on raising investment in technical transformation projects Under the high attention of the party committees and governments at all levels in Wenzhou City and district, the company promoted the design, civil engineering, decoration and acceptance of raising investment projects simultaneously It is expected that by the end of this year, the infrastructure project with a construction area of 59000 square meters will be completed and put into operation in early 2019 At that time, the fund-raising projects - R & D building, preparation building and three API workshops, logistics and supporting plants will be put into use In particular, after the completion of the preparation production line, it will increase from the existing 4 to 12, greatly improving the company's production capacity; third, it will focus on technology research and development In August last year, the provincial "sincere medicine big health research institute" was listed, in March this year, the company established the "academician expert workstation", in April, the company and Wenzhou Medical University jointly established the "new drug research institute" At the same time, actively promote the drug consistency evaluation At present, the company has 9 products under evaluation, and some products will be in the clinical pre experiment stage After the signing ceremony, sincerity pharmaceutical also signed a strategic cooperation framework agreement with Wenzhou yitiefutian Equity Investment Fund Management Co., Ltd., and signed a regional marketing signing ceremony with Hefei Yifan biomedical Co., Ltd., Zhejiang Kaixin Pharmaceutical Co., Ltd., Hainan Beite Pharmaceutical Co., Ltd., etc Original title: sincere pharmaceutical "three centers" officially settled in Shanghai reporter: Lin yinghan Dong